Evidence map›Paper›PMID 32730935›Full record

ArticleBone2020

Current anti-depressant use is associated with cortical bone deficits and reduced physical function in elderly women.

Sanchita Agarwal, Carmen Germosen, Nayoung Kil, Mariana Bucovsky, Ivelisse Colon, John Williams, Elizabeth Shane, Marcella D Walker

Open access · greenAbstract read
In one paragraph

Article in Bone, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bone diseases and the COVID-19 pandemic.Archives of endocrinology and metabolism · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sanchita AgarwalDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Carmen GermosenDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Nayoung KilDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Mariana BucovskyDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Ivelisse ColonDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
John WilliamsDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Elizabeth ShaneDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
Marcella D WalkerDivision of Endocrinology, Columbia University Irving Medical Center, New York, NY 10032, United States of America. Electronic address: mad2037@columbia.edu.
Columbia University Irving Medical Center · US

Funding

VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEP01AG007232 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SCHUPF, NICOLE · 1989 to 2008
$21.7M
Epidemiology of Biomarkers of Risk and Progression in LOADR01AG037212 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, SCHUPF, NICOLE · 2010 to 2015
$10.1M
Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's DiseaseRF1AG054023 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P · 2016 to 2018
$8.9M
Skeletal Microstructure - Racial Differences and Genetic ContributorsR01AR071986 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WALKER, MARCELLA DONOVAN · 2018 to 2022
$2.9M
NIAMS NIH HHS R01 AR071986NIA NIH HHS P01 AG007232NIA NIH HHS R01 AG037212NIA NIH HHS RF1 AG054023
6 · The paper itself

Abstract

backgroundAnti-depressants, particularly selective serotonin reuptake inhibitors (SSRIs), are associated with an increased risk of fracture. The mechanism is unclear and may be due to effects on bone metabolism, muscle strength, falls or other factors. It is unknown if serotonin norepinephrine reuptake inhibitors (SNRIs) have similar effects.

methodsWe compared musculoskeletal health in current female anti-depressant users and non-users from a population-based multiethnic (35.6% black, 22.3% white and 42.1% mixed) cohort study of adults ≥65 years old in New York (N = 195) using dual x-ray absorptiometry (DXA), trabecular bone score (TBS), vertebral fracture assessment (VFA), high resolution peripheral quantitative computed tomography (HR-pQCT), body composition, and grip strength.

resultsCurrent anti-depressant users were more likely to be white than non-white (OR 1.9, 95% CI 1.2-2.9) and were shorter than non-users, but there were no differences in age, weight, BMI, physical activity, calcium/vitamin D intake, falls or self-rated health. There were more pelvic fractures in current vs. non-users (7.1% vs. 0%, p = 0.04). Age- and weight-adjusted T-score by DXA was lower in current users at the 1/3-radius (-1.6 ± 1.1 vs. -1.0 ± 1.4, p = 0.04) site only. There was no difference in TBS, vertebral fractures or fat/lean mass by DXA. Age- and weight-adjusted grip strength was 13.3% lower in current users vs. non-users (p = 0.04). By HR-pQCT, age- and weight-adjusted cortical volumetric BMD (Ct. vBMD) was 4.8% lower in users vs. non-users at the 4% radius site (p = 0.007). A similar cortical pattern was seen at the proximal (30%) tibia. When assessed by anti-depressant class, deteriorated cortical microstructure was present only in SSRI users at the radius and only in SNRI users at the proximal tibia.

conclusionsAnti-depressant use is associated with cortical deterioration and reduced physical function, but effects may be class-specific. These findings provide insight into the mechanism by which anti-depressants may contribute to the increased fracture risk in older women.

Indexed as

Bone DensityCortical BoneAbsorptiometry, PhotonAdultAgedCohort StudiesFemaleHumansRadiusTibiaAnti-depressantsFractureMicrostructureSelective serotonin reuptake inhibitorsSkeletal

Identifiers

PMID32730935
PMCPMC7502521
OpenAlexW3044769186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.